Polyunsaturated fatty acids, the most important being arachidonic acid, are liberated from phospholipids and further transformed into biologically active compounds that can act as mediators or modulators of inflammatory reactions. Three main groups of derivatives-prostaglandins, thromboxanes, and leukotrienes-are derived from arachidonic acid by oxygenation and further enzymatic actions.' The leukotrienes comprise peptidolipids which are the slow-reacting substances of anaphylaxis and a dihydroxy-eicosatetraenoic acid known as leukotriene B4 (LTB4).
The role of LTB4 would appear to be as a local mediator released by resident and newly arriving cells in developing inflammatory exudates in response to a variety of inflammatory stimuli. Its major effects are to enhance the ability of inflammatory leucocytes to penetrate the vascular endothelium, to stimulate their movement towards inflammatory foci, and, after arrival, to cause degranulation and the release of lysosomal enzymes. In addition LTB4 acts in concert with vasodilatory prostaglandins, PGE2 and PGI2, to produce an increased vascular permeability and to cause plasma exudation.2
The leukotriene therefore satisfies one important criterion for a putative mediator of inflammation in that it produces effects in vitro and in vivo, which provide a facsimile of characteristic events in inflammatory sequences. Other criteria are whether it may be detected at inflammatory sites and whether it is removed from such sites by further metabolism.
The present work was designed to investigate its formation and presence in synovial fluid of patients Accepted for publication 28 October 1982.
Correspondence to Professor M. J. H. Smith. with rheumatoid arthritis (RA) and to obtain evidence that there are mechanisms to inactivate LTB4 in the inflammatory exudate.
Materials and methods
We studied 12 patients, 9 male and 3 female, with either classical or definite RA (American Rheumatism Association's criteria) being treated with nonsteroidal anti-inflammatory drugs but neither gold nor penicillamine. Two of the patients were also receiving prednisolone (6 mg per day). The Synovial fluid specimens aspirated from the knee joint were diluted with an equal volume of 0*9 % w/v sterile saline containing heparin (20 units ml-) and the supematant was stored at -20°C after removal of the cells by centrifugation at 500 g for 10 min. The supematant was analysed for its content of LTB4 and the cells for their ability to both produce and metabolise the leukotriene.
LTB4 was separated and characterised from the supernatant by passage through an octadecylsilyl silica column3 followed by reverse-phase highpressure liquid chromatography (HPLC), and it was assayed either physicochemically, by measurement of ultraviolet absorbance at 260, 270 and 281 nm,4 or biologically by aggregation of rat peritoneal polymorphonuclear leucocytes (PMNs).5 One or both of these assay procedures were used to study both the generation of LTB4 from suspensions of the synovial fluid cells exposed to the calcium ionophore A23 1876 and also the removal of exogenous LTB4 added either to the suspended synovial cells or to PMNs 677 prepared from human blood.5 Further experiments were performed with tritium-labelled LTB4 obtained by incubating rat peritoneal PMNs with 3H-arachidonic acid (Radiochemical Centre, Amersham, Bucks). The disappearance of the radioactive LTB4 and the formation of tritiated polar metabolites from human peripheral PMNs were monitored.7
Results
By the ultraviolet absorption method no LTB4 was detected in the relevant HPLC fraction from any of the synovial fluid specimens. In our hands the lower limit of detection with this technique is 2 5 ng ml-'that is, 25 to 60 ng per whole specimen. 8 The results of the more sensitive bioassay procedure, given in Table 1 , show that detectable amounts of the LTB4 were present, the mean value (±SEM) was 0 34 ± 0*14 ng ml-, and the range was 0 to 17 ng per whole specimen.
When the synovial fluid cells were exposed to the calcium ionophore the major lipoxygenase-derived products were produced in similar quantities to those reported for human peripheral PMNs.47 These products comprise 5-monohydroxyeicosatetraenoic acid, LTB4, the all trans-isomers of the leukotriene, and its more polar 20-hydroxy and 20-carboxy derivatives.
The results in Fig. 1 show the rate of disappearance of 100 ng of LTB4 assessed by measurement of its aggregating effect in suspensions containing 107 cells ml-of either human synovial or human peripheral leucocytes. The rate of removal of the leukotriene by each cell type was both rapid, the half life being 
